Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

Recruiting now

Conditions studied: Gastrointestinal Neoplasms, Benign Neoplasm of Intestinal Tract

In brief

To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.

Key facts

Study ID

NCT01750619

Run by

California Pacific Medical Center Research Institute

People needed

8000

Starts

2011-07-01

Expected to finish

2030-12-01

Last updated by the study team

2026-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients age >18 years that have been referred for endoscopic treatment of GI lesions.

You may not qualify if…

• Patients for whom endoscopic treatment was not performed.

Where it is running

• Interventional Endoscopy Services — San Francisco, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.